Landscape Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Landscape Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$320K	Buy	+5,596	New	+$307K	0.02%	552
2026 Q1	–	Sell	-7,996	Closed	-$475K	–	744
2025 Q4	$475K	Sell	7,996 -11,821	-60%	-$644K	0.03%	493
2025 Q3	$1.07M	Sell	19,817 -467	-2%	-$26.7K	0.07%	358
2025 Q2	$1.12M	Buy	20,284 +10,390	+105%	+$612K	0.09%	301
2025 Q1	$699K	Buy	+9,894	New	+$666K	0.06%	363
2018 Q4	–	Sell	-2,078	Closed	-$202K	–	863
2018 Q3	$202K	Buy	+2,078	New	+$207K	0.01%	649
2018 Q1	–	Sell	-11,901	Closed	-$1.06M	–	483
2017 Q4	$1.06M	Buy	+11,901	New	+$1.03M	0.09%	222

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Landscape Capital Management's BMRN Position: Q2 2026 in Review

Landscape Capital Management opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 5,596 shares worth $320K. The stake represents 0.02% of the portfolio and ranks #552 among its holdings. This is a return to the name: Landscape Capital Management previously reported a position in BMRN as recently as Q4 2025.

Landscape Capital Management first reported a position in BMRN in Q4 2017 and has held it in 7 quarters since. The position peaked at $1.12M in Q2 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Landscape Capital Management held 5,596 shares of BioMarin Pharmaceuticals worth $320K as of Q2 2026.
BioMarin Pharmaceuticals was a new Landscape Capital Management position in Q2 2026.
BioMarin Pharmaceuticals made up 0.02% of Landscape Capital Management's portfolio in Q2 2026, its #552 holding.
Landscape Capital Management first reported a position in BioMarin Pharmaceuticals in Q4 2017 and has held it in 7 quarters since.
Landscape Capital Management's BioMarin Pharmaceuticals position peaked at $1.12M in Q2 2025.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.